Aptose Biosciences Inc. (APS) Fundamentals

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Luxeptinib, its panFMS-like tyrosine kinase 3 / pan-Bruton's tyrosine kinase inhibitor, is enrolling patients in a Phase 1, multicenter, open label, dose-escalation study with expansions to assess the safety, tolerability, PK, and preliminary efficacy of CG-806 in patients with chronic lymphocytic leukemia (CLL/SLL) or non-Hodgkin lymphomas (NHL). HM43239 is an oral potent myeloid kinome inhibitor, targeting a constellation of kinases operative in myeloid malignancies.
SHARE INFORMATION
Market Cap$ 130.043.156
Shares Outstanding92.229.189
Float90.978.701
Percent Float98,64%
Short Interest817.916,00
Short Percent Float100,0%
Short Interest Ratio15,6386
Short Interest Date2022-04-30
Latest Fiscal Dividend Per Share$ 0,00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0,92
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0,00
Dividend (5 Years)$ 0,00
Ex Dividend Date-
Dividend Rate$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions88
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months3.421.279
Institutional Holdings Percent34,8%
Institutional Sold Previous 3 Months1.638.757
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months2.200.000
Insider Holdings Percent1,3
Insider Sold Previous 3 Months-
Insider Shares Owned35.756.820
TRADING INFO
52 Week High$ 6,98
52 Week Low$ 1,17
52 Week High Change$ -76,18
21 Day Moving Average$ 1,4467
21 Day Extended Moving Average$ 1,446
50 Day Moving Average$ 1,5184
50 Day Extended Moving Average$ 1,5205
200 Day Moving Average$ 2,2926
200 Day Extended Moving Average$ 2,4293
10 Day Average Volume29.227
20 Day Average Volume27.190
30 Day Average Volume27.325
50 Day Average Volume36.608
Alpha0.019529
Beta1.201912
Standard Deviation0.22693
R20.046702
7 Day Price Change$ 0,03
7 Day Percent Change2,17%
21 Day Price Change$ -0,04
21 Day Percent Change-2,76%
30 Day Price Change$ -0,16
30 Day Percent Change-10,19%
Month to Date Price Change$ -0,10
Month to Date Percent Change-6,62%
Quarter to Date Price Change$ -0,29
Quarter to Date Percent Change-17,06%
180 Day Price Change$ -1,86
180 Day Percent Change-56,88%
200 Day Price Change$ -1,16
200 Day Percent Change-45,14%
Year to Date Price Change$ -0,32
Year to Date Percent Change-18,5%

Aptose Biosciences Inc. (APS) Key Ratios

PROFITABILITY
EBIT Margin0,0%
EBITDA Margin0,0%
Pre-Tax Profit Margin0,0%
Profit Margin Count0,0%
Gross Margin0,0%
Profit Margin TOT0,0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0,00
Revenue (3 Years)$ 0,00
Revenue (5 Years)$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book1,56
Total Debt To Equity0,01
Int Coverage0,00
Current Ratio9,80
Leverage Ratio1,10
Quick Ratio9,50
Long Term Debt To Capital0,00
VALUATION MEASURES
PE Ratio-1,60
Enterprise Value$ 38.232.797
Price to Sales0,00
Price to Free Cash-2,40
PE High Last 5 Years-2,10
Price To Book1,49
Price To Cash Flow0,00
PE Low Last 5 Years-7,40
Price to Tangible Book1,56
MANAGEMENT EFFECTIVENESS
Receivables Turnover0,00
Invoice Turnover0,00
Assets Turnover0,00
Return Assets-66,83
Return on Equity-71,90
Return on Capital-68,91

Aptose Biosciences Inc. (APS) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOWilliam G. Rice
Emplyoees41
Last AuditUQ
CIK0000882361
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address251 Consumers Road
Suite 1105
Toronto, ON M2J 4R3
Websitehttps://www.aptose.com
Facsimile-
Telephone+1 650 718-5028
Emailir@aptose.com
Seu Histórico Recente
TSX
APS
Aptose Bio..
Registre-se agora para acompanhar essas ações ao vivo no Monitor ADVFN.

O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é completamente grátis para você usar.

Cotações da NYSE e AMEX têm defasagem de no mínimo 20 minutos.
Quaisquer outras cotações têm defasagem de no mínimo 15 minutos quando não especificado.
Em caso de dúvidas por favor entre em contato com o suporte: suporte@advfn.com.br ou (11) 4950 5808.

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

P: V:br D:20220518 23:00:41